M2与M1闭塞机械取栓:倾向性匹配及早期神经功能改善分层评估
本研究为回顾性队列研究,利用Top-Gear影像库纳入接受血管内治疗的孤立性M1或M2闭塞患者。经倾向性评分匹配后,M2闭塞患者90天良好预后率显著高于M1闭塞。M2闭塞是良好预后的独立预测因素,且获益集中于中重度基线缺损患者。
要点
- M2闭塞取栓后良好预后率高于M1,死亡率更低。
- M2闭塞取栓获益以基线NIHSS≥6的中重度患者为主。
- 早期神经功能改善在M2闭塞中预示良好功能结局,在M1中不一定预示。
核心结论
- M2闭塞位置是机械取栓后良好预后的独立预测因素(OR 2.32,95% CI 1.01-5.3,p=0.04)。
- M2闭塞取栓获益在中重度基线缺损患者中尤为明显,提示获益可能集中于NIHSS≥6人群。
- 早期神经功能改善与M2闭塞良好功能结局相关,但在M1闭塞中并不相关。
研究设计与样本
- 回顾性队列研究,数据来自Top-Gear影像库,入组接受血管内治疗的孤立性M1或M2闭塞患者。
- 171例符合纳入标准(M1 n=98,M2 n=73),倾向性评分匹配后每组n=52。
- 匹配变量包括年龄、性别、卒中前mRS、入院NIHSS、静脉tPA使用及再通次数(>3次)。
诊断标准与关键数值
- 匹配后M2闭塞良好预后(90天mRS≤2)率为51.9%,M1为30.8%(p=0.04)。
- 匹配后M2闭塞死亡率为19.3%,M1为38.5%(p=0.05)。
- M2闭塞独立预测良好预后的OR为2.32,95% CI 1.01-5.3,p=0.04。
- 匹配后分层分析显示,轻度卒中(NIHSS≤5)中早期神经功能改善少见。
- 中度和重度M2卒中患者早期神经功能改善发生率分别为75%和65.6%。
临床应用与阅片要点
- 阅片报告M2闭塞位置时,需同时结合基线NIHSS判断取栓潜在获益。
- M2闭塞伴早期神经功能改善提示预后较好,但在M1闭塞中不应同等解读。
- 近期随机对照试验中NIHSS≥6的M2闭塞患者可能代表性不足,临床决策需注意。
局限性
- 回顾性队列研究设计本身存在选择偏倚风险。
- 数据仅来自单一影像库(Top-Gear),外推性有待验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: Recent randomized controlled trials of endovascular therapy (EVT) for medium-vessel occlusions yielded neutral results, partly attributed to enrollment of patients with mild deficits and exclusive reliance on the 90-day mRS. Using propensity score matching (PSM), we compared mechanical thrombectomy (MT) outcomes between M1 and M2 occlusions.
METHODS: This retrospective cohort study used data from the Top-Gear imaging repository. Patients with isolated M1 or M2 occlusions who underwent EVT were included. PSM was performed on age, sex, pre-stroke mRS, admission NIHSS, IV tPA administration, and number of recanalization passes (>3). Primary outcome was 90-day mRS ≤2. Secondary outcomes included ENI and 90-day mRS distribution.
RESULTS: Of 419 screened patients, 171 met eligibility criteria (M1: n=98, M2: n=73). After PSM (n=52 per group), M2 occlusions were associated with significantly higher rates of good outcome (51.9% vs. 30.8%, p=0.04) and lower mortality (19.3% vs. 38.5%, p=0.05). In multivariable logistic regression, M2 occlusion was independently associated with favorable outcome (OR 2.32, 95% CI 1.01-5.3, p=0.04). Stratified analysis by baseline NIHSS after PSM showed that ENI was uncommon in mild strokes (NIHSS ≤5) but occurred in 75% and 65.6% of patients with moderate and severe M2 strokes, respectively. Among M2 patients with ENI, 64.5% achieved mRS ≤2 at 90 days, compared to 33.3% of M1 patients with ENI.
CONCLUSIONS: The M2 occlusion location was independently associated with favorable outcome following MT, with a particularly pronounced benefit among patients with moderate-to-severe baseline deficits. ENI was associated with good functional outcome in M2 occlusions, not in M1 occlusions. These findings suggest that the benefit of MT in M2 occlusions may be concentrated in patients with NIHSS ≥6, a population potentially underrepresented in recent RCTs.
引用
- Zidan, Zimmermann, Kniep, et al. Mechanical Thrombectomy for M2 versus M1 Occlusions: A Propensity-Matched Analysis With Severity-Stratified Assessment of Early Neurological Improvement. AJNR Am J Neuroradiol. 2026. PMID: 42276759. doi:10.3174/ajnr.A9471
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。